Although challenging, laboratories really should do their best to help keep an up-to-date listing of relevant DBZDs in their MS confirmation assays and take into account regardless of whether these DBZDs will likely be detected on their certain immunoassay platforms.Benzodiazepine use and abuse pose sizeable burdens over the health and safety of it